Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.

Cancer letters - 18 May 2009

Paris Pamela L, Kobayashi Yasuko, Zhao Qiang, Zeng Wei, Sridharan Shivaranjani, Fan Tina, Adler Howard L, Yera Emmanuel R, Zarrabi M H, Zucker Stanley, Simko Jeffry, Chen Wen-Tien, Rosenberg Jonathan

Abstract excerpt

Circulating tumor cells (CTCs) hold promise for studying advanced prostate cancer. A functional collagen adhesion matrix (CAM) assay was used to enrich CTCs from prostate cancer patients' blood. CAM ingestion and epithelial immuno-staining identified CTCs, which were genotyped using oligonucleotide array comparative genomic hybridization. The highest CTC counts were observed in men with metastatic castration...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasm Metastasis

Share to Neoplastic Cells, Circulating

Share to Orchiectomy

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 19162393
DOI: 10.1016/j.canlet.2008.12.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.PMID 19162393Read ↗

An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate CancerSemantic proximity Read ↗

An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.Semantic proximity Read ↗

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancerSemantic proximity Read ↗

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.Semantic proximity Read ↗

Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate CancerSemantic proximity Read ↗

Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.Semantic proximity Read ↗

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.Semantic proximity Read ↗

RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistanceSemantic proximity Read ↗

Low Abundance of Circulating Tumor DNA in Localized Prostate CancerSemantic proximity Read ↗

Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.Semantic proximity Read ↗

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer PatientsSemantic proximity Read ↗

Low Abundance of Circulating Tumor DNA in Localized Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.